Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT

被引：0
作者：
Deborah M. Broadbent
Amu Wang
Christopher P. Cheyne
Marilyn James
James Lathe
Irene M. Stratton
John Roberts
Tracy Moitt
Jiten P. Vora
Mark Gabbay
Marta García-Fiñana
Simon P. Harding
机构：
[1] University of Liverpool,Department of Eye and Vision Science, Institute of Life Course and Medical Sciences
[2] Member of Liverpool Health Partners,St Paul’s Eye Unit
[3] Liverpool University Hospitals Foundation Trust,Department of Biostatistics
[4] Member of Liverpool Health Partners,Division of Rehabilitation, Ageing and Wellbeing, School of Medicine
[5] University of Liverpool,Gloucestershire Retinal Research Group
[6] Member of Liverpool Health Partners,Department of Diabetes and Endocrinology
[7] Clinical Trials Research Centre,Department of Health Services Research
[8] University of Nottingham,undefined
[9] Cheltenham General Hospital,undefined
[10] Mersey Diabetes Support Group,undefined
[11] Royal Liverpool University Hospital,undefined
[12] University of Liverpool,undefined
[13] Member of Liverpool Health Partners,undefined
[14] Brownlow Health Centre,undefined
[15] Member of Liverpool Health Partners,undefined
来源：
Diabetologia | 2021年 / 64卷
关键词：
Diabetic retinopathy; Individualised; Personalised; Risk-based; Screening; Systematic; Variable interval;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：56 / 69
页数：13
相关论文
共 89 条
[1]  
Flaxel CJ(1989)Diabetic retinopathy Preferred Practice Pattern Acta Diabetol 10 143-144
[2]  
Adelman RA(2020)Diabetic retinopathy and maculopathy Ophthalmology 127 P66-P145
[3]  
Bailey ST(2014)Incidence of sight threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study Exp Clin Endocrinol Diabetes 122 387-390
[4]  
Hammes HP(2003)Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme Lancet 361 195-200
[5]  
Lemmen KD(2013)Evidence-based Danish guidelines for screening of diabetic retinopathy Diabetologia 56 1716-1725
[6]  
Bertram B(2018)Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy Acta Ophthalmol 96 763-769
[7]  
Younis N(2011)A simple risk stratification for time to development of sight-threatening diabetic retinopathy Diabetes Care 34 1318-1319
[8]  
Broadbent DM(2013)Extending the diabetic retinopathy screening interval beyond 1 year: a systematic review Diabetes Care 36 580-585
[9]  
Vora JP(2016)The UK’s National Programme for IT: why was it dismantled? Br J Ophthalmol 100 105-114
[10]  
Harding SP(2017)Personalized medicine for diabetes Health Serv Manag Res 30 2-9
123456789